Sanofi to promote 51% stake in Opella to CD&R, 1% to BPI By Reuters
PARIS (Reuters) - France will take a stake in Sanofi (NASDAQ:)'s Opella by way of the Public Funding Financial institution ...
Friday, December 20, 2024
Tag: Sanofi
Sanofi eyes for accelerated growth in India; plans fast-tracking of product pipeline
Aiming for a "fair share" in the Indian pharmaceutical market, French drug major Sanofi plans to introduce new drugs and ...
Teva teams with Sanofi on inflammatory bowel treatment
Israeli drug developer Teva Pharmaceutical Industries Ltd. (NYSE: TEVA; TASE: TEVA) and French pharmaceutical company Sanofi (Nasdaq: SNY; Euronext: ...
Sanofi stock rises as Dupixent shows benefit in lung disease smokers, meets phase 3 goals
JHVEPhoto Sanofi (NASDAQ:SNY) and Regeneron Pharmaceuticals' (NASDAQ:REGN) Dupixent met the main goal and all key secondary goals of a phase ...
Provention Bio stock rockets ~260% on ~$2.9B acquisition by Sanofi (PRVB)
Maks_Lab Sanofi (NASDAQ:SNY) is acquiring Red Bank, N.J.- based diabetes drugmaker Provention Bio (NASDAQ:PRVB) for ~$2.9B. Under the agreement, Sanofi ...
LLY Stock Dives — Taking Novo, Sanofi With It — After Fake Twitter Account Promises Free Insulin
Elon Musk's new pay-for-play verification system on Twitter shook pharmaceutical mainstay Eli Lilly (LLY) — leading LLY stock to skid ...
Purchase, Promote or Maintain: What ought to traders do with Mazagaon Dock, Rites and Sanofi India?
The Indian market ended destructive for the second consecutive day on Tuesday monitoring its international friends. Benchmarks Nifty50 and the ...
RECOMMENDED
Get the latest news and follow the coverage of Investing, World News, Stocks, Market Analysis, Business & Financial News, and more from the top trusted sources.